64
Views
14
CrossRef citations to date
0
Altmetric
Original Research

Relationship between IGF2BP2 and IGFBP3 polymorphisms and susceptibility to non-small-cell lung cancer: a case–control study in Eastern Chinese Han population

, , , , &
Pages 2965-2975 | Published online: 28 Aug 2018

References

  • TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
  • ZhangJYChanEKPengXXTanEMA novel cytoplasmic protein with RNA-binding motifs is an autoantigen in human hepatocellular carcinomaJ Exp Med199918971101111010190901
  • NielsenJChristiansenJLykke-AndersenJJohnsenAHWewerUMNielsenFCA family of insulin-like growth factor II mRNA-binding proteins represses translation in late developmentMol Cell Biol1999192126212709891060
  • GuLShigemasaKOhamaKIncreased expression of IGF II mRNA-binding protein 1 mRNA is associated with an advanced clinical stage and poor prognosis in patients with ovarian cancerInt J Oncol200424367167814767552
  • PngKJHalbergNYoshidaMTavazoieSFA microRNA regulon that mediates endothelial recruitment and metastasis by cancer cellsNature2011481738019019422170610
  • LiuBChenYYangJLncRNAs are altered in lung squamous cell carcinoma and lung adenocarcinomaOncotarget2017815242752429127903974
  • KhandwalaHMMcCutcheonIEFlyvbjergAFriendKEThe effects of insulin-like growth factors on tumorigenesis and neoplastic growthEndocr Rev200021321524410857553
  • PollakMInsulin-like growth factor physiology and neoplasiaGrowth Horm IGF Res200010Suppl AS6S710984271
  • PapadimitrakopoulouVABrownENLiuDDThe prognostic role of loss of insulin-like growth factor-binding protein-3 expression in head and neck carcinogenesisCancer Lett2006239113614316181731
  • LeeHYMoonHChunKHEffects of insulin-like growth factor binding protein-3 and farnesyltransferase inhibitor SCH66336 on Akt expression and apoptosis in non-small-cell lung cancer cellsJ Natl Cancer Inst200496201536154815494604
  • WangYASunYPalmerJIGFBP3 Modulates lung tumori-genesis and cell growth through IGF1 signalingMol Cancer Res201715789690428330997
  • LiuGZhuTCuiYCorrelation between IGF2BP2 gene polymorphism and the risk of breast cancer in Chinese Han womenBiomed Pharmacother20156929730025661373
  • TerryKLTworogerSSGatesMACramerDWHankinsonSECommon genetic variation in IGF1, IGFBP1 and IGFBP3 and ovarian cancer riskCarcinogenesis200930122042204619858071
  • ChengIDelellis HendersonKHaimanCAGenetic determinants of circulating insulin-like growth factor (IGF)-I, IGF binding protein (BP)-1, and IGFBP-3 levels in a multiethnic populationJ Clin Endo-crinol Metab200792936603666
  • DemingSLRenZWenWGenetic variation in IGF1, IGF-1R, IGFALS, and IGFBP3 in breast cancer survival among Chinese women: a report from the Shanghai Breast Cancer StudyBreast Cancer Res Treat2007104330931917063263
  • ZhaiYZhaoWHChenCMVerification on the cut-offs of waist circumference for defining central obesity in Chinese elderly and tall adultsZhonghua Liu Xing Bing Xue Za Zhi201031662162521163090
  • ZhangXZhangSLiYAssociation of obesity and atrial fibrillation among middle-aged and elderly ChineseInt J Obes2009331113181325
  • TangWZhangSQiuHGenetic variations in MTHFR and esophageal squamous cell carcinoma susceptibility in Chinese Han populationMed Oncol201431591524687778
  • QiuHWangYKangMThe relationship between IGF2BP2 and PPARG polymorphisms and susceptibility to esophageal squamous-cell carcinomas in the eastern Chinese Han populationOnco Targets Ther2017105525553229200867
  • LiuXChenZZhaoXEffects of IGF2BP2, KCNQ1 and GCKR polymorphisms on clinical outcome in metastatic gastric cancer treated with EOF regimenPharmacogenomics201516995997026115082
  • YangHPLiuJFRaoJInsulin-like growth factor binding protein-3 (IGFBP-3) genetic variant and the risk of esophageal squamous cell carcinoma in a Chinese populationGenet Mol Res20141324146415324938707
  • LiuCTangWChenSIGFBP3 polymorphisms and risk of esophageal cancer in a Chinese populationInt J Clin Exp Med201589170061701426629256
  • YinJWangXWeiJInterleukin 12B rs3212227 T > G polymorphism was associated with an increased risk of gastric cardiac adenocar-cinoma in a Chinese populationDis Esophagus201528329129824529168
  • ZhangSWangYJiangHAssociation between the CD28 IVS3 +17T>C (rs3116496) polymorphism and cancer susceptibility: a meta-analysis involving 8,843 subjectsInt J Clin Exp Med2015810173531736126770327
  • ZhangSWangYJiangHPeroxisome proliferator-activated receptor gamma rs1801282 C>G polymorphism is associated with polycystic ovary syndrome susceptibility: a meta-analysis involving 7,069 subjectsInt J Clin Exp Med2015810174181742926770332
  • TangWWangYJiangHProgrammed death-1 (PD-1) rs2227981 C > T polymorphism is associated with cancer susceptibility: a meta-analysisInt J Clin Exp Med2015812222782228526885204
  • QiuHChengCWangYInvestigation of cyclin D1 rs9344 G>A polymorphism in colorectal cancer: a meta-analysis involving 13,642 subjectsOnco Targets Ther201696641665027822068
  • TangWQiuHDingHAssociation between the STK15 F31I polymorphism and cancer susceptibility: a meta-analysis involving 43,626 subjectsPLoS One2013812e8279024349361
  • TangWQiuHJiangHLack of association between cytotoxic T-lymphocyte antigen 4 (CTLA-4) -1722T/C (rs733618) polymorphism and cancer risk: from a case-control study to a meta-analysisPLoS One201494e9403924710335
  • TangWWangYChenSInvestigation of cytotoxic T-lymphocyte antigen 4 polymorphisms in gastric cardia adenocarcinomaScand J Immunol201683321221826709093
  • ShiYYHeLSHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism lociCell Res2005152979815740637
  • DaiNJiFWrightJMinichielloLSadreyevRAvruchJIGF2 mRNA binding protein-2 is a tumor promoter that drives cancer proliferation through its client mRNAs IGF2 and HMGA1Elife20176e2715528753127
  • BarghashAGolob-SchwarzlNHelmsVHaybaeckJKesslerSMElevated expression of the IGF2 mRNA binding protein 2 (IGF2BP2/IMP2) is linked to short survival and metastasis in esophageal adeno-carcinomaOncotarget2016731497434975027391348
  • ZhangLFPeiQYangGPThe effect of IGF2BP2 gene polymorphisms on pioglitazone response in Chinese type 2 diabetes patientsPharmacology2014943–411512225247335
  • HuangQYinJYDaiXPIGF2BP2 variations influence repa-glinide response and risk of type 2 diabetes in Chinese populationActa Pharmacol Sin201031670971720523342
  • SainzJRudolphAHoffmeisterMEffect of type 2 diabetes predisposing genetic variants on colorectal cancer riskJ Clin Endocrinol Metab2012975E845E85122419714
  • ZhuQGZhangSMDingXXHeBZhangHQDriver genes in non-small cell lung cancer: Characteristics, detection methods, and targeted therapiesOncotarget2017834576805769228915704
  • YanBGuanDWangCAn integrative method to decode regulatory logics in gene transcriptionNat Commun201781104429051499
  • HeBLuCZhengGCombination therapeutics in complex diseasesJ Cell Mol Med201620122231224027605177
  • HorikawaYMiyakeKYasudaKReplication of genome-wide association studies of type 2 diabetes susceptibility in JapanJ Clin Endocrinol Metab20089383136314118477659